Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 187

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Impact of a High Loading Dose of Atorvastatin on Contrast-Induced Acute Kidney Injury

Open access
Quintavalle, Cristina, Fiore, Danilo, De Micco, Francesca, Visconti, Gabriella, Focaccio, Amelia, Golia, Bruno, Ricciardelli, Bruno, Donnarumma, Elvira, Bianco, Antonio, Zabatta, Maria Assunta, Troncone, Giancarlo, Colombo, Antonio, Briguori, Carlo, Condorelli, Gerolama · 2012 · Circulation

Abstract

Background—: The role of statins in the prevention of contrast-induced acute kidney injury (CIAKI) is controversial. Methods and Results—: First, we investigated the in vivo effects of atorvastatin on CIAKI. Patients with chronic kidney disease enrolled in the Novel Approaches for Preventing or Limiting Events (NAPLES) II trial were randomly assigned to (1) the atorvastatin group (80 mg within 24 hours before contrast media [CM] exposure; n=202) or (2) the control group (n=208). All patients received a high dose of N -acetylcysteine and sodium bicarbonate solution. Second, we investigated the in vitro effects of atorvastatin pretreatment on CM-mediated modifications of intracellular pathways leading to apoptosis or survival in renal tubular cells. CIAKI (ie, an increase >10% of serum cystatin C concentration within 24 hours after CM exposure) occurred in 9 of 202 patients in the atorvastatin group (4.5%) and in 37 of 208 patients in the control group (17.8%) ( P =0.005; odds ratio=0.22; 95% confidence interval, 0.07–0.69). CIAKI rate was lower in the atorvastatin group in both diabetics and nondiabetics and in patients with moderate chronic kidney disease (estimated glomerular filtration rate, 31–60 mL/min per 1.73 m 2 ). In the in vitro model, pretreatment with atorvastatin (1) prevented CM-induced renal cell apoptosis by reducing stress kinases activation and (2) restored the survival signals (mediated by Akt and ERK pathways). Conclusions—: A single high loading dose of atorvastatin administered within 24 hours before CM exposure is effective in reducing the rate of CIAKI. This beneficial effect is observed only in patients at low to medium risk.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.112.103317

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 187

Metadata

Authors
Quintavalle, C., Fiore, D., De Micco, F., Visconti, G., Focaccio, A., Golia, B., Ricciardelli, B., Donnarumma, E., Bianco, A., Zabatta, M. A., Troncone, G., Colombo, A., Briguori, C., & Condorelli, G.
Venue
Circulation
Published
2012-12-18
Volume
126
Issue
25
Pages
3008-3016
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2161089842
Cited by
187
References
2
FWCI
17.61
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Impact of a High Loading Dose of Atorvastatin on Contrast-Induced Acute Kidney Injury. https://app.cochat.ai/papers/10.1161/circulationaha.112.103317
The paper
Quintavalle, C., Fiore, D., De Micco, F., Visconti, G., Focaccio, A., Golia, B., Ricciardelli, B., Donnarumma, E., Bianco, A., Zabatta, M. A., Troncone, G., Colombo, A., Briguori, C., & Condorelli, G. (2012). Impact of a High Loading Dose of Atorvastatin on Contrast-Induced Acute Kidney Injury. Circulation. https://doi.org/10.1161/circulationaha.112.103317

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.